ctrl K

Price Alert

Fennec Pharmaceuticals In... (FENC)

NASDAQ: FENC · Real-Time Price · USD

9.22

0.20 (2.22%)

At close: Sep 09, 2025, 3:59 PM

9.22

0.00%

After-hours: Sep 09, 2025, 04:04 PM EDT

Fennec Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	47.54M	21.25M	1.53M	n/a
Cost of Revenue	3.18M	1.26M	86K	n/a
Gross Profit	44.35M	19.99M	1.45M	n/a
Operating Income	2.57M	-12.77M	-22.59M	-17.22M
Interest Income	1.59M	441K	195K	54K
Pretax Income	-71K	-16.05M	-23.71M	-17.35M
Net Income	-436K	-16.05M	-24.84M	-17.46M
Selling & General & Admin	41.48M	32.71M	20.51M	12.24M
Research & Development	307K	56K	3.53M	4.98M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	41.79M	32.76M	24.04M	17.22M
Interest Expense	4.07M	3.39M	978K	126K
Selling & Marketing Expenses	18.43M	12.12M	2.79M	n/a
Cost & Expenses	44.97M	34.02M	24.12M	17.22M
Income Tax Expense	365K	n/a	1.13M	110K
Shares Outstanding (Basic)	27.29M	26.57M	26.27M	26.01M
Shares Outstanding (Diluted)	27.29M	26.57M	26.27M	26.01M
EPS (Basic)	-0.02	-0.6	-0.95	-0.67
EPS (Diluted)	-0.02	-0.6	-0.95	-0.67
EBITDA	3.6M	-12.36M	-22.59M	-123K
EBIT	2.57M	-12.65M	-22.74M	-17.07M
Depreciation & Amortization	1.03M	287K	149K	17.22M